Study guide
12.4 Neonatal Respiratory Distress: TTN, RDS, Meconium Aspiration & Persistent Pulmonary Hypertension (PPHN)
NCC Inpatient Obstetric Nursing RNC-OB
Track your progress as you read
Finished sections get a check mark.
1 Chapter 0: Introduction & How to Use This Guide
0.1 About the RNC-OB Credential & Exam Blueprint 0.2 How to Use This Study Guide & Clinical Learning Methodology
2 Chapter 1: Pregnancy Complications — Maternal Medical Conditions
1.1 Hypertensive Disorders of Pregnancy 1.2 HELLP Syndrome & Hepatic Disorders of Pregnancy 1.3 Diabetes Mellitus in Pregnancy 1.4 Maternal Cardiac and Respiratory Disorders 1.5 Infectious Diseases in Inpatient Obstetrics 1.6 Hematologic, Endocrine, Connective Tissue & Other Systemic Disorders
3 Chapter 2: Pregnancy Complications — Preterm Labor, Multiple Gestation, Placental & Fetal Disorders
2.1 Psychosocial Disorders, Substance Use & Environmental Exposures 2.2 Preterm Labor: Assessment, Tocolysis & Neuroprotection 2.3 Multiple Gestation: Placentation, Chorionicity & Complications 2.4 Placental Disorders: Previa, Abruption, Vasa Previa & PAS 2.5 Fetal Growth Disorders & Amniotic Fluid Complications
4 Chapter 3: Antenatal Fetal Assessment & Surveillance
3.1 Antenatal Testing Methods & Indications for Fetal Surveillance 3.2 Nonstress Test (NST), Contraction Stress Test (CST) & Biophysical Profile (BPP) 3.3 Diagnostic Prenatal Procedures (Amniocentesis, CVS, PUBS, cfDNA & Ultrasound) 3.4 Fetal Oxygenation Physiology & Acid-Base Regulation 3.5 Umbilical Cord Blood Gas Collection & Clinical Interpretation
5 Chapter 4: Fetal Assessment & Electronic Fetal Monitoring (EFM)
4.1 NICHD Electronic Fetal Monitoring Terminology & Baseline Features 4.2 FHR Decelerations, Acceleration Patterns & Uterine Activity 4.3 The NICHD Three-Tier Fetal Heart Rate Classification System 4.4 Intrauterine Resuscitation & Clinical Action Protocols 4.5 Fetal Arrhythmias, Dysrhythmias & Artifact Differentiation
6 Chapter 5: Labor & Birth Physiology — Mechanics, Cardinal Movements, Stages & Support
5.1 Physiology of Labor & Uterine Mechanics 5.2 Pelvic Anatomy, Fetal Lie, Presentation & Cardinal Movements of Labor 5.3 Stages of Labor, Cervical Dilatation Dynamics & Progression Guidelines 5.4 Intrapartum Admission Assessment, Obstetric Triage & Membrane Rupture Evaluation 5.5 Labor Support, Non-Pharmacologic Pain Management & Physiologic Birth Practices
7 Chapter 6: Labor & Birth Interventions — Cervical Ripening, Induction, Pain Management & Anesthesia
6.1 Bishop Scoring, Pre-Induction Cervical Ripening & Mechanical Methods 6.2 Oxytocin Administration, Titration Protocols & Uterine Tachysystole Management 6.3 Nonpharmacologic Comfort & Labor Pain Management Strategies 6.4 Systemic Opioid Analgesia & Inhaled Nitrous Oxide 6.5 Neuraxial Analgesia, Spinal/Epidural Complications & General Anesthesia
8 Chapter 7: Labor & Birth — Operative Deliveries, TOLAC/VBAC & Special Intrapartum Procedures
7.1 External Cephalic Version (ECV) & Malpresentation Management 7.2 Operative Vaginal Delivery: Vacuum Extraction & Forceps-Assisted Birth 7.3 Cesarean Delivery: Surgical Indications, Intraoperative Management & PACU Recovery 7.4 Trial of Labor After Cesarean (TOLAC) & Vaginal Birth After Cesarean (VBAC) 7.5 Special Intrapartum Procedures: Amniotomy, Amnioinfusion, Cervical Ripening & Labor Augmentation
9 Chapter 8: Obstetric Emergencies & Critical Care
8.1 Shoulder Dystocia Management & HELPERR Protocol 8.2 Umbilical Cord Prolapse & Feto-Vascular Emergencies 8.3 Uterine Rupture & Acute Uterine Inversion 8.4 Amniotic Fluid Embolism (Anaphylactoid Syndrome of Pregnancy) 8.5 Intraamniotic Infection (Chorioamnionitis) & Maternal Sepsis
10 Chapter 9: Postpartum Physiology & Immediate Recovery Care
9.1 Postpartum Physiologic Changes & Maternal Systemic Adaptations 9.2 Fourth Stage of Labor & Immediate Recovery Care 9.3 Routine Postpartum Nursing Assessment & Clinical Care (BUBBLE-HE) 9.4 Rh Isoimmunization, Alloimmunization & Postpartum Immunizations 9.5 Postpartum Discharge Teaching, Warning Signs & Maternal Safety
11 Chapter 10: Postpartum Adaptation, Hemorrhage & Clinical Complications
10.1 Postpartum Hemorrhage: Definition, Risk Stratification, 4 Ts, QBL & Pharmacotherapy 10.2 Postpartum Infections: Endometritis, Wound Infections, Sepsis & Postpartum Pyrexia 10.3 Thromboembolic Disorders: DVT, Pulmonary Embolism & Septic Pelvic Thrombophlebitis 10.4 Perinatal Mood & Anxiety Disorders: Postpartum Blues, PPD, Anxiety & Postpartum Psychosis 10.5 Lactation Physiology, Breastfeeding Complications, Engorgement & Medication Safety
12 Chapter 11: Newborn Care, Transition & Clinical Assessment
11.1 Neonatal Physiologic Transition & Cardiorespiratory Adaptation 11.2 Immediate Newborn Care, Apgar Scoring & Delivery Room Stabilization 11.3 Newborn Thermoregulation & Pathophysiology of Cold Stress 11.4 Gestational Age & Neonatal Growth Assessment 11.5 Comprehensive Newborn Head-to-Toe Examination & Normal Variants
13 Chapter 12: Newborn Complications, Resuscitation & High-Acuity Management
12.1 Neonatal Resuscitation Program (NRP 8th Edition) & Delivery Room Resuscitation 12.2 Neonatal Glucose Homeostasis, Hypoglycemia Screening & Clinical Management 12.3 Neonatal Hyperbilirubinemia, Bilirubin Metabolism & Phototherapy Protocols 12.4 Neonatal Respiratory Distress: TTN, RDS, Meconium Aspiration & Persistent Pulmonary Hypertension (PPHN) 12.5 Neonatal Sepsis, Congenital Infections & Neonatal Abstinence Syndrome (NAS/NOWS)
14 Chapter 13: Professional Practice, Legal-Ethical Frameworks, Patient Safety & Quality Improvement
13.1 Legal Aspects of Perinatal Nursing & High-Risk Documentation Standards 13.2 Ethical Principles in Perinatal Care & Maternal-Fetal Conflicts 13.3 Quality Improvement, Perinatal Safety Initiatives & AIM Bundles 13.4 Patient Safety Culture, Team Communication & Clinical Escalation 13.5 Evidence-Based Practice, Research Utilization & Perinatal Guidelines
12.4 Neonatal Respiratory Distress: TTN, RDS, Meconium Aspiration & Persistent Pulmonary Hypertension (PPHN)
Key Takeaways Explain This Topic AI
Clinical Recognition & Silverman-Andersen Scoring: Cardinal signs of neonatal respiratory distress include tachypnea (>60 breaths/min), retractions, nasal flaring, and expiratory grunting (compensatory glottic narrowing to maintain functional residual capacity); the 10-point Silverman-Andersen Index objectively scores distress, with values ≥7 reflecting severe respiratory failure.
Transient Tachypnea of the Newborn (TTN): Caused by delayed clearance of fetal lung liquid via epithelial sodium channels (ENaC), characteristically following elective cesarean delivery without labor; chest radiography reveals perihilar streaking, fluid in interlobar fissures, and mild hyperaeration, resolving spontaneously within 24 to 72 hours.
Respiratory Distress Syndrome (RDS): Surfactant deficiency in preterm infants (<35 weeks) causes elevated alveolar surface tension, diffuse microatelectasis, and hypoxemia; chest radiography shows diffuse reticulogranular 'ground-glass' opacities with air bronchograms, managed with early Bubble CPAP and endotracheal surfactant instillation.
Meconium Aspiration Syndrome (MAS): Aspiration of particulate meconium produces small airway obstruction with a ball-valve air-trapping mechanism (predisposing 15%–30% of infants to pneumothorax), chemical pneumonitis, and surfactant inactivation; chest radiography shows coarse, patchy, asymmetric fluffy infiltrates with hyperinflation.
Persistent Pulmonary Hypertension of the Newborn (PPHN): Elevated pulmonary vascular resistance forces right-to-left shunting across the patent ductus arteriosus and foramen ovale, confirmed by a pre-ductal (right hand) to post-ductal (foot) SpO2 gradient ≥5% to 10%; primary medical management utilizes Inhaled Nitric Oxide (iNO at 20 ppm) for selective pulmonary vasodilation.
Last updated: August 2026
Clinical Recognition & Scoring of Respiratory Distress
Neonatal respiratory distress is the most common cause of admission to the neonatal intensive care unit (NICU). The neonatal respiratory system is mechanically disadvantaged compared to that of adults: neonates possess a highly compliant, cartilaginous chest wall , a relatively non-compliant lung parenchyma , narrow upper and lower airways offering high airflow resistance, and an immature diaphragm composed of fewer fatigue-resistant slow-twitch (Type I) muscle fibers. +---------------------------------------------------------------------------------------------------+
- | CARDINAL SIGNS OF NEONATAL RESPIRATORY DISTRESS |
- +---------------------------------------------------------------------------------------------------+
- Physical Sign Physiological Mechanism & Clinical Significance
- --------------------- ---------------------------------------------------------------------------
Tachypnea • Respiratory Rate >60 breaths/min (sustained).
• Compensatory attempt to maintain minute ventilation (Minute Vent = RR x Vt)
in the presence of decreased tidal volume.
- --------------------------------------------------------------------------------------------------
- Intercostal / Subcostal • Highly compliant cartilaginous ribcage is drawn inward when high negative
Retractions pleural pressures are generated to inflate stiff, non-compliant lungs.
- --------------------------------------------------------------------------------------------------
- Nasal Flaring • Active dilation of anterior nares during inspiration mediated by the
alae nasi muscles. Reduces upper airway resistance by up to 30-40%.
---------------------------------------------------------------------------------------------------
Expiratory Grunting • Partial closure of vocal cords (glottis) during active expiration.
• Generates physiological auto-PEEP (Positive End-Expiratory Pressure),
preventing end-expiratory alveolar collapse and maintaining FRC.
---------------------------------------------------------------------------------------------------
Central Cyanosis • Bluish discoloration of mucous membranes, tongue, and core trunk.
• Indicates presence of ≥3.0 to 5.0 g/dL of deoxygenated hemoglobin in
arterial blood; reflects severe arterial hypoxemia.
- --------------------------------------------------------------------------------------------------
- Seesaw Breathing • Paradoxical breathing where abdomen expands while chest collapses during
- inspiration, signaling severe diaphragmatic fatigue and impending failure.
- +---------------------------------------------------------------------------------------------------+
- The Silverman-Andersen Respiratory Retraction Index
The Silverman-Andersen Index is the gold-standard clinical scoring tool for evaluating neonatal respiratory distress severity (opposite of Apgar scoring: higher score = worse distress). +---------------------------------------------------------------------------------------------------+
- | SILVERMAN-ANDERSEN RETRACTION INDEX |
- +---------------------------------------------------------------------------------------------------+
- Assessment Sign Score = 0 Score = 1 Score = 2
- --------------------------- -------------------- ------------------------ ---------------------
- [ 1 ] Upper Chest Movement Synchronous chest & Lag on inspiration Seesaw paradoxical
- abdominal expansion (chest lags behind) respirations
- --------------------------------------------------------------------------------------------------
- [ 2 ] Lower Chest Retraction No retractions Just visible / mild Marked / deep
- visible intercostal retractions intercostal sinking
- --------------------------------------------------------------------------------------------------
- [ 3 ] Xiphoid Retraction No xiphoid Just visible / mild Marked / prominent
- retraction substernal notch xiphoid retraction
- --------------------------------------------------------------------------------------------------
- [ 4 ] Nares Dilation No flaring Minimal / mild flaring Marked / wide flaring
- --------------------------------------------------------------------------------------------------
- [ 5 ] Expiratory Grunt None audible Audible only with Audible with unaided
- stethoscope ear at bedside
- +---------------------------------------------------------------------------------------------------+
- Scoring Interpretation: 0 = No distress | 1-3 = Mild distress | 4-6 = Moderate distress | ≥7 = Severe
Transient Tachypnea of the Newborn (TTN / "Wet Lung")
Transient Tachypnea of the Newborn (TTN) is a benign, self-limiting condition resulting from delayed reabsorption and clearance of fetal alveolar lung liquid via the pulmonary lymphatic and capillary beds.
Pathophysiology & Risk Factors
During labor, maternal and fetal surges in catecholamines and cortisol switch the pulmonary epithelium from active chloride secretion to active sodium absorption via apical Epithelial Sodium Channels (ENaC) . In the absence of labor (e.g., scheduled cesarean delivery) or in late-preterm gestations, ENaC channels are under-activated, leaving 30 mL/kg 30\text{ mL/kg} 30 mL/kg of fluid trapped in alveolar spaces. +---------------------------------------------------------------------------------------------------+
- | TTN CLINICAL PROFILE & RADIOGRAPHIC FINDINGS |
- +---------------------------------------------------------------------------------------------------+
Risk Factors • Scheduled Cesarean delivery without labor (Primary Risk Factor).
• Late preterm gestation (34 to 36 6/7 weeks).
• Maternal diabetes / Macrosomia.
• Precipitous labor / Maternal asthma.
---------------------------------------------------------------------------------------------------
Clinical Course • Tachypnea (RR 60 to 120 breaths/min) developing within 1 to 2 hours of birth.
• Mild intercostal retractions, nasal flaring, and occasional grunting.
• Clear breath sounds or mild moist coarse crackles.
• Typically resolves spontaneously within 24 to 72 hours.
---------------------------------------------------------------------------------------------------
Chest X-Ray Findings • Prominent perihilar vascular streaking ("Sunburst pattern").
• Fluid accumulation in the interlobar horizontal fissures.
• Symmetrical lung hyperaeration with flattened diaphragmatic domes.
• Mild cardiomegaly secondary to lymphatic engorgement.
---------------------------------------------------------------------------------------------------
Nursing & Medical Care • Neutral thermal environment to reduce metabolic oxygen demand.
• Humidified supplemental oxygen titrated via nasal cannula or CPAP (4-6 cmH2O).
- NPO STATUS & GAVAGE FEEDING: If respiratory rate >70-80 breaths/min,
- oral bottle/breast feeding is strictly withheld to prevent aspiration;
maintain hydration with IV fluids (D10W at 60-80 mL/kg/day).
- +---------------------------------------------------------------------------------------------------+
- Respiratory Distress Syndrome (RDS / Hyaline Membrane Disease)
Respiratory Distress Syndrome (RDS) is the leading cause of respiratory failure and mortality in preterm infants, caused by a deficiency of endogenous pulmonary surfactant combined with structural immaturity of the neonatal lungs.
Surfactant Bio-Mechanics
Pulmonary surfactant, produced by Type II alveolar pneumocytes beginning at 24 to 28 weeks and reaching functional maturity by 35 weeks, is composed of 90% phospholipids ( dipalmitoylphosphatidylcholine [DPPC] ) and 10% proteins ( SP-A, SP-B, SP-C, SP-D ). By reducing surface tension at the air-liquid interface, surfactant prevents end-expiratory alveolar collapse according to the Law of Laplace ( P = 2 T r P = \frac{2T}{r} P = r 2 T ). Without surfactant, surface tension remains high, causing massive microatelectasis, hypoventilation, hypercapnia, severe hypoxemia, and mixed respiratory/metabolic acidosis. +---------------------------------------------------------------------------------------------------+
- | RDS CLINICAL PROFILE & SURFACTANT REPLACEMENT |
- +---------------------------------------------------------------------------------------------------+
Risk Factors • Prematurity (<35 weeks; incidence inversely proportional to gestation).
• Maternal Diabetes: High fetal insulin antagonizes cortisol-induced
surfactant synthesis in Type II pneumocytes.
• Perinatal Asphyxia / Cold Stress / Male sex / Second twin.
---------------------------------------------------------------------------------------------------
Clinical Manifestations • Onset immediately at birth or within 4 to 6 hours.
• Marked tachypnea, prominent expiratory grunting, severe sternal/costal
retractions, nasal flaring, and central cyanosis in room air.
• Decreased breath sounds with diffuse fine inspiratory crackles.
---------------------------------------------------------------------------------------------------
Chest X-Ray Triad 1. Diffuse, uniform reticulogranular "Ground-Glass" opacification.
2. Prominent Air Bronchograms (air-filled bronchi visible against dense lung).
3. Low Lung Volumes / Hypoexpansion (bell-shaped thorax, <7-8 posterior ribs).
- --------------------------------------------------------------------------------------------------
- Therapeutic Protocol • Early Continuous Positive Airway Pressure (Bubble CPAP 5 to 7 cmH2O)
instituted in delivery room to splint alveoli and establish FRC.
• Exogenous Surfactant Therapy: Natural bovine/porcine extracts (Poractant
alfa / Curosurf 200 mg/kg; Beractant / Survanta 100 mg/kg).
• Administered via ETT or LISA (Less Invasive Surfactant Administration)
technique using a thin catheter while spontaneously breathing on CPAP.
• Oxygen Titration: Maintain SpO2 91% to 95% (strict targets to avoid
Retinopathy of Prematurity [ROP] and Bronchopulmonary Dysplasia [BPD]).
+---------------------------------------------------------------------------------------------------+
Meconium Aspiration Syndrome (MAS)
Meconium Aspiration Syndrome (MAS) occurs when a fetus experiences intrauterine hypoxia or distress, triggering colonic peristalsis, relaxation of the anal sphincter, and deep fetal gasping that aspirates particulate meconium into the tracheobronchial tree. +---------------------------------------------------------------------------------------------------+
- | THE QUADRUPLE PATHOLOGICAL CASCADE OF MAS |
- +---------------------------------------------------------------------------------------------------+
[ 1. MECHANICAL AIRWAY OBSTRUCTION ]
- Complete Obstruction: Atelectasis distal to meconium plugs -> severe V/Q mismatch.
- Partial Obstruction: "BALL-VALVE EFFECT" (Air enters around plug during inspiration,
- but airways narrow during expiration, trapping air) -> Alveolar Overdistention,
Air Leaks, PNEUMOTHORAX (15-30% incidence), and Pneumomediastinum.
- │
- ▼
- [ 2. CHEMICAL PNEUMONITIS & INFLAMMATION ]
- Bile salts, pancreatic enzymes, and free fatty acids in meconium trigger acute airway necrosis,
alveolar epithelial sloughing, mucosal edema, and proteinaceous capillary leak.
- │
- ▼
- [ 3. SURFACTANT INACTIVATION ]
- Meconium directly displaces surfactant from alveolar surfaces, inactivates surfactant proteins
SP-A and SP-B, and accelerates surfactant degradation -> Widespread Microatelectasis.
- │
- ▼
- [ 4. PERSISTENT PULMONARY HYPERTENSION (PPHN) ]
- Parenchymal lung injury, severe hypoxemia, and acidosis induce profound pulmonary arteriolar
vasoconstriction, triggering secondary PPHN in up to 20-30% of MAS cases.
Clinical Presentation & Radiography of MAS
Epidemiology & Signs: Primarily affects term and post-term infants (>41 weeks) or growth-restricted neonates. Infant is covered in thick, pea-soup meconium with green/yellow staining of the umbilical cord, fingernails, and skin. Displays immediate severe respiratory distress, barrel-shaped chest (hyperinflation), and diffuse coarse crackles and rhonchi.
Chest X-Ray Hallmarks: Patchy, asymmetric, fluffy infiltrates ("rope-like / coarse streaking") alternating with areas of hyperlucent air trapping / hyperinflation , flattened diaphragms, and frequent pneumothorax .
Persistent Pulmonary Hypertension of the Newborn (PPHN)
Persistent Pulmonary Hypertension of the Newborn (PPHN) is a life-threatening hemodynamic disorder characterized by sustained elevation of Pulmonary Vascular Resistance (PVR) following birth. When PVR fails to decline, pulmonary artery pressure exceeds systemic arterial pressure, forcing deoxygenated blood to shunt right-to-left across the Foramen Ovale and Ductus Arteriosus , resulting in profound, refractory systemic hypoxemia. +---------------------------------------------------------------------------------------------------+
- | HEMODYNAMICS & SHUNTING PATHOLOGY OF PPHN |
- +---------------------------------------------------------------------------------------------------+
- [ Elevated Pulmonary Vascular Resistance (PVR > SVR) ]
- │
- ▼
- [ Right Ventricular & Right Atrial Hypertension ]
- │
- ┌──────────────────────┴──────────────────────┐
- ▼ ▼
- [ FORAMEN OVALE SHUNT ] [ DUCTUS ARTERIOSUS SHUNT ]
- Deoxygenated Right Atrial blood Deoxygenated Pulmonary Artery blood
- streams into Left Atrium shunts into Descending Aorta
- │ │
- ▼ ▼
- [ Global Systemic Hypoxemia ] [ DIFFERENTIAL CYANOSIS ]
- (Low Brain & Coronary SpO2) (Pre-ductal SpO2 > Post-ductal SpO2 by ≥5-10%)
- Diagnostic Hallmarks of PPHN
Pre-Ductal vs. Post-Ductal Oxygen Gradient: Simultaneous pulse oximeter probes are placed on the Right Hand (Pre-ductal) and Either Foot (Post-ductal) . A S p O 2 SpO_2 Sp O 2 difference ≥ 5 % to 10 % \ge 5\%\text{ to }10\% ≥ 5% to 10% (or arterial P a O 2 PaO_2 P a O 2 difference ≥ 15 – 20 mmHg \ge 15\text{--}20\text{ mmHg} ≥ 15 – 20 mmHg ) confirms a significant right-to-left shunt across a patent ductus arteriosus.
Hyperoxia Test: The infant is placed in 100% FiO2 for 10 minutes. If arterial P a O 2 PaO_2 P a O 2 remains < 100 – 150 mmHg <100\text{--}150\text{ mmHg} < 100 – 150 mmHg , right-to-left shunting (PPHN or Cyanotic Congenital Heart Disease) is confirmed over parenchymal lung disease.
Echocardiography (Gold Standard): Directly visualizes elevated right ventricular systolic pressure (systolic flattening or leftward bowing of the interventricular septum), right-to-left or bidirectional shunt across the PDA/PFO, and measurable tricuspid regurgitation (TR) jet velocity.
High-Acuity Management Protocol for PPHN
Inhaled Nitric Oxide (iNO): Selective pulmonary vasodilator of choice (initial dose 20 ppm ). Diffuses into pulmonary vascular smooth muscle, activating soluble guanylyl cyclase to increase cyclic GMP (cGMP), inducing intense pulmonary vasodilation without causing systemic hypotension.
Inotropic & Vasopressor Support: Maintain systemic vascular resistance (SVR) higher than PVR (reversing right-to-left shunt) using Dopamine, Epinephrine, or Milrinone (inodilator improving RV output and reducing PVR).
Oxygenation Targets: Maintain pre-ductal S p O 2 92 % – 97 % SpO_2\text{ }92\%\text{--}97\% Sp O 2 92% – 97% and P a O 2 60 % – 80 mmHg PaO_2\text{ }60\%\text{--}80\text{ mmHg} P a O 2 60% – 80 mmHg . Avoid hypoxemia (triggers pulmonary vasoconstriction) and excessive hyperoxia ( P a O 2 > 100 mmHg PaO_2 >100\text{ mmHg} P a O 2 > 100 mmHg ). Sedation with fentanyl to prevent agitation-induced pulmonary hypertensive crises.
Extracorporeal Membrane Oxygenation (ECMO): Indicated when the Oxygenation Index ( O I OI O I ) exceeds 40 despite maximal iNO and ventilation. Oxygenation Index (OI) = Mean Airway Pressure (MAP) × FiO 2 × 100 Post-ductal P a O 2 \text{Oxygenation Index (OI)} = \frac{\text{Mean Airway Pressure (MAP)} \times \text{FiO}_2 \times 100}{\text{Post-ductal } PaO_2} Oxygenation Index (OI) = Post-ductal P a O 2 Mean Airway Pressure (MAP) × FiO 2 × 100
High-Yield Comparative Matrix: Neonatal Respiratory Disorders
Feature / Disorder Transient Tachypnea (TTN) Respiratory Distress Syndrome (RDS) Meconium Aspiration (MAS) Persistent Pulmonary HTN (PPHN)
Target Population Term / Late Preterm, Elective C-Section without labor Preterm infants (<35 weeks), IDM Post-term (>41 wk), Term, Growth Restricted (IUGR) Term / Late Preterm with MAS, Sepsis, Hypoxia, or CDH
Underlying Etiology Retained fetal lung fluid; delayed ENaC clearance Deficiency of pulmonary surfactant (DPPC) Airway obstruction (ball-valve), chemical pneumonitis Failure of PVR to drop; right-to-left PFO/PDA shunting
Onset of Symptoms Birth to 2 hours of life Birth to 4–6 hours (progressively worsens) Immediate at delivery; severe distress Birth to 12 hours (severe labile hypoxemia)
Chest X-Ray Appearance Perihilar streaking ("sunburst"), fissure fluid, hyperinflation Reticulogranular "ground-glass" with air bronchograms, low volumes Coarse, patchy asymmetric fluffy infiltrates, air trapping, pneumothorax Normal lung fields OR underlying parenchymal disease (MAS/RDS)
Distinguishing Hallmark Rapid spontaneous resolution within 24–72 hours Surfactant response; premature gestation Meconium staining of cord/skin; barrel chest Pre-ductal vs. post-ductal S p O 2 SpO_2 Sp O 2 gradient ≥ 5 – 10 % \ge 5\text{--}10\% ≥ 5 – 10%
Primary Treatment Supportive CPAP (4–6 cmH2O), O2, NPO if RR >70–80 Bubble CPAP (5–7 cmH2O), Exogenous Surfactant Mechanical ventilation, Surfactant, Antibiotics Inhaled Nitric Oxide (iNO 20 ppm) , ECMO if OI >40